Clinical trial
A Dose-Response Study of the Cognitive and Physiological Effects of tDCS to the DLPFC
NCT04175041 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Dose-Response Study of the Cognitive and Physiological Effects of tDCS to the DLPFC
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- July 9, 2019
- Completion date
- May 31, 2026
- Enrollment
- 104 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
attention deficit hyperactivity disorder